[Tissue factor molecules and some other indices of coagulation hemostasis in patients with rheumatic heart disease].
- Published Article
- Publication Date
Jan 01, 2008
This comparative study of interleukins, tissue factor activity, and certain parameters of coagulation hemostasis included patients with rheumatic heart disease. It revealed an increased production of proinflammatory cytokines including interleukin-1b (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha) in all groups of patients. The procoagulative activity was also enhanced and positively correlated with the IL-1 beta level. Tissue factor activity was directly proportional to the concentration of IL-1 beta and inversely proportional to that of interleukin-4 (IL-4).
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 07/03/2016 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/18819347